Arcellx is a top competitor of Neoleukin. Arcellx is a Public company that was founded in 2014 in Gaithersburg, Maryland. Arcellx operates in the Biotechnology industry. Compared to Neoleukin, Arcellx has 11 fewer employees.
Jubilant Therapeutics is seen as one of Neoleukin's biggest rivals. Jubilant Therapeutics was founded in 2019, and is headquartered in Bedminster, New Jersey. Jubilant Therapeutics is in the Biotechnology industry. Jubilant Therapeutics generates $ less revenue vs. Neoleukin.